Topical ketoprofen patch

Drugs in R and D

Volumn 6, Issue 6, 2005, Pages 337-344

  Mazìeres, Bernard ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; KETOPROFEN; KETOTOP; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PLACEBO;

AEROSOL; ANALGESIA; BURN; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CREAM; DAILY LIFE ACTIVITY; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG FORMULATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PENETRATION; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; DYSPEPSIA; ERYTHEMA; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GEL; HUMAN; INCIDENCE; INFLAMMATION; KNEE SURGERY; NAUSEA; NONARTICULAR RHEUMATISM; NONHUMAN; PAIN; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN; SKIN DISEASE; SKIN IRRITATION; SKIN MANIFESTATION; SOFT TISSUE INFECTION; SUBCUTANEOUS FAT; SYSTEMIC DISEASE; TRANSDERMAL PATCH; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; KETOPROFEN; PAIN;

EID: 27744605325     PISSN: 11745886     EISSN: 11745886     Source Type: Journal    
DOI: 10.2165/00126839-200506060-00003     Document Type: Review

References (41)

1. Moore RA, Tramer MR, Carroll D, et al. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998; 316 (7128): 333-8
2. McCormack K, Brune K. Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs: a survey of their analgesic efficacy. Drugs 1991; 41 (4): 533-47
3. Bannwarth B, Demotes-Mainard F, Schaeverbeke T, et al. Where are peripheral analgesics acting? Ann Rheum Dis 1993; 52 (1): 1-4
4. Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs 1996; 52 Suppl. 5: 13-23
5. Wynne HA, Campbell M. Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs). Pharmacoeconomics 1993; 3 (2): 107-23
6. Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 2000; 60 (3): 555-74
7. Grahame R. Transdermal non-steroidal anti-inflammatory agents. Br J Clin Pract 1995; 49 (1): 33-5
8. Mason L, Moore RA, Edwards JE, et al. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract 2004; 5 (1): 10
9. Rolf C, Movin T, Engstrom B, et al. An open, randomized study of ketoprofen in patients in surgery for Achilles or patellar tendinopathy. J Rheumatol 1997; 24 (8): 1595-8
10. Rolf C, Engstrom B, Beauchard C, et al. Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy. Rheumatology (Oxford) 1999; 38 (6): 564-7
11. Jokhio IA, Siddiqui KA, Waraich T, et al. Study of efficacy and tolerance of ketoprofen and diclofenac sodium in the treatment of acute rheumatic and traumatic conditions. J Pak Med Assoc 1998; 48 (12): 373-6
12. Patel RK, Leswell PF. Comparison of ketoprofen, piroxicam, and diclofenac gels in the treatment of acute soft-tissue injury in general practice. General Practice Study Group. Clin Ther 1996; 18 (3): 497-507
13. Orudis (ketoprofen) Prescribing Information. Wyeth 2003
14. Cordero JA, Camacho M, Obach R, et al. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur J Pharm Biopharm 2001; 51 (2): 135-42
15. Cordero JA, Alarcon L, Escribano E, et al. A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs. J Pharm Sci 1997; 86 (4): 503-8
16. Flouvat B, Roux A, Delhotal-Landes B. Pharmacokinetics of ketoprofen in man after repeated percutaneous administration. Arzneimittel Forschung 1989; 39 (7): 812-5
17. Cannavino CR, Abrams J, Palinkas LA, et al. Efficacy of transdermal ketoprofen for delayed onset muscle soreness. Clin J Sport Med 2003; 13 (4): 200-8
18. Rovati LC, Setnikar I, Genazzani AR. Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application: a randomized, double-blind, placebo-controlled study. Italian Menopause Research Group. Gynecol Endocrinol 2000; 14 (4): 282-91
19. Notelovitz M, Cassel D, Hille D, et al. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause. Am J Obstet Gynecol 2000; 182 (1 Pt 1): 7-12
20. Zieman M, Guillebaud J, Weisberg E, et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002; 77 (2 Suppl. 2): S13-8
21. Audet MC, Moreau M, Koltun WD, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA 2001; 285 (18): 2347-54
22. Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992; 44 (3): 498-529
23. Hays JT, Croghan IT, Schroeder DR, et al. Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. Am J Public Health 1999; 89 (11): 1701-7
24. Tonnesen P, Paoletti P, Gustavsson G, et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J 1999; 13 (2): 238-46
25. Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001; 322 (7295): 1154-8
26. Mystakidou K, Befon S, Kouskouni E, et al. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial. Anticancer Res 2001; 21 (3C): 2225-30
27. Mertin D, Cordes G, Heiling T. Ketoprofen TDS, a new approach for the therapy of rheumatism and sport injuries [abstract]. Proceedings of the 2nd World Meeting APGI/APV; 1998 May 25-28; Paris, France. 893-4
28. Klaffenbach P, Vollmer U. In vitro percutaneous absorption in isolated skin: test-product ketoprofen TDS patch in comparison with ketoprofen gel. Report on file September 2000
29. Osterwalder A, Reiner V, Reiner G, et al. Tissue absorption and distribution of ketoprofen after patch application in subjects undergoing knee arthroscopy or endoscopic carpal ligament release. Arzneimittel Forschung 2002; 52 (11): 822-7
30. Crestani S, Ismaili S. IPAS-KETO/TDS-280-01, Final report: systemic bioavailability study of ketoprofen administered to healthy volunteers as TDS patch (test formulation) vs gel (reference formulation). Report on file June 2002
31. Verbeeck RK, Corman CL, Wallace SM, et al. Single and multiple dose pharmacokinetics of enteric coated ketoprofen: effect of cimetidine. Eur J Clin Pharmacol 1988; 35 (5): 521-7
32. Data on file, Zambon Group, Bresso, Italy
33. Mazieres B, Rouanet S, Guillon Y, et al. Topical ketoprofen patch in the treatment of tendinitis: a randomized, double blind, placebo controlled study. J Rheumatol 2005; 32: 1563-70
34. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344 (21): 1594-602
35. Mazieres B, Rouanet S, Velicy J, et al. Topical ketoprofen patch (100mg) in the treatment of ankle sprain: a randomized, double-blind, placebo-controlled study. Am J Sports Med 2005; 33: 515-23
36. Lee JS, Hobden E, Stiell IG, et al. Clinically important change in the visual analog scale after adequate pain control. Acad Emerg Med 2003; 10 (10): 1128-30
37. Cepeda MS, Africano JM, Polo R, et al. What decline in pain intensity is meaningful to patients with acute pain? Pain 2003; 105 (1-2): 151-7
38. US Food and Drug Administration. Guidelines for the clinical value of analgesic drugs. 1992
39. Dionne RA, Gordon SM, Tahara M, et al. Analgesic efficacy and pharmacokinetics of ketoprofen administered into a surgical site. J Clin Pharmacol 1999; 39 (2): 131-8
40. Patel RK, Leswell PF. Comparison of ketoprofen, piroxicam, and diclofenac gels in the treatment of acute soft-tissue injury in general practice. Clin Ther 1996; 18 (3): 497-507
41. Airaksinen O, Venalainen J, Pietilainen T. Ketoprofen 2.5% gel versus placebo gel in the treatment of acute soft tissue injuries. Int J Clin Pharmacol Ther Toxicol 1993; 31 (11): 561-3